Researchers show that the transcription factor E2F-1 activates both p53 and p73, playing a crucial role in cell death. This finding raises the possibility of using activators of E2F-1 to tip the balance towards apoptosis, potentially leading to new cancer therapies.
Scientists develop a method to precisely adjust nanopore sizes using ultraviolet light, enabling the creation of tunable zeolites for enhanced membrane-based oxygen-nitrogen separation. This technology has potential applications in sensor arrays, nanoreactors, and optical devices.
A new study aims to improve adolescent girls' fitness levels and reduce their risk of obesity. The Trial of Activity in Adolescent Girls (TAAG) project will test whether structured physical activity programs can increase fitness and prevent decline, with a focus on underrepresented groups.
Researchers at UCSF Comprehensive Cancer Center are testing an immunotherapy treatment that involves collecting stem cells from a patient's sibling to attack the cancer. The trial aims to confirm previous NIH study results and explore its potential in treating solid cancers, including prostate and melanoma.
Researchers identify Dmrt1 as a crucial gene for normal mammalian testis development, providing insights into human testicular degeneration syndrome. The discovery also highlights surprising molecular conservation between vertebrates and invertebrates.
Researchers at UCSF and Compugen identified a new chemokine CXCL16 that recruits immune cells to sites of infection. The novel molecule binds to the CXCR6 receptor, which is exploited by HIV viruses for entry into human cells.
US presidential nominees Governor George W. Bush and Vice President Al Gore express differing views on global warming, environmental policies, and education reforms in their responses to the Science questionnaire. They agree on supporting research funding and tax credits for biomedical research.
Researchers at Duke University Medical Center have discovered a gene responsible for hereditary benign intraepithelial dyskeratosis (HBID), a rare eye disease primarily among the Haliwa-Saponi tribe. The gene causes a 'founder's effect,' leading to abnormal growths on mucosal linings, affecting vision and bloodshot eyes.